Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series A round brings $33mm to smoking cessation company Chrono Therapeutics

Executive Summary

Canaan Partners and 5AM Ventures led a $33mm Series A financing for transdermal drug/device company Chrono Therapeutics Inc. Fountain Healthcare Partners, Mayo Clinic, GE Ventures, and 26 undisclosed investors participated. Executives from Canaan Partners, 5AM Ventures, and Fountain joined Chrono’s board.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Transdermal
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register